Idiopathic Infantile Hypercalcemia - Mild Form

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Idiopathic Infantile Hypercalcemia - Mild Form trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT03301038

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

This study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of…

United States60 participantsStarted 2018-07-25

Treatment: Rifampin

All recent trials (2 shown)

UnknownPhase 1

NCT03384121

The Antibiotic Rifampin to Reduce High Levels of Blood and Urine Calcium in IIH

Idiopathic infantile hypercalcemia(IIH) is a rare,genetic disorder of mineral metabolism. Biallelic loss of functions mutations of CYP24A1, the gene encoding th…

Canada5 participantsStarted 2018-02-22

Treatment: Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension